课题基金 / 基金详情

MONITORING SURFACTANT USE IN THE NEONATAL INTENSIVE CARE UNIT

MONITORING SURFACTANT USE IN THE NEONATAL INTENSIVE CARE UNIT
监测新生儿重症监护病房中表面活性剂的使用
批准号：
6244126
负责人：
AARON HAMVAS
金额：
$2.25万
依托单位：
WASHINGTON UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
1997
资助国家：
美国
项目状态：
已结题
起止时间：
1997-01-06 至 1997-11-30
来源：
https://reporter.nih.gov/project-details/6244126
关键词：
clinical research drug adverse effect drug screening /evaluation human data human therapy evaluation infant human (0-1 year) medical records neonatal intensive care pulmonary surfactants respiratory disorder chemotherapy

项目摘要

项目成果

AARON HAMVAS的其他基金

相关文献

中文摘要
翻译
本研究将描述使用表面活性剂的经验 圣路易斯新生儿重症监护室（NICU）的治疗 儿童医院这项研究是对新生儿重症监护病房婴儿的图表回顾 接受表面活性剂治疗的患者和未接受表面活性剂治疗的对照组 得到了表面活性剂。 审查将描述使用和不良反应 反应.
英文摘要
This study will characterize the experience with the use of surfactant therapy in the neonatal intensive care unit (NICU) at St. Louis Children's Hospital. The study is a chart review of infants in the NICU who received surfactants therapy and matched controls who did not received surfactant. The review will characterize usage and adverse reactions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neonatal Research Network: the Lurie Children's - Northwestern University Study Center
Integrated analysis of autonomic biomarkers in prematurity-related ventilatory control: Determination of neurorespiratory maturation and predictors of co-morbidity risk
Integrated analysis of autonomic biomarkers in prematurity-related ventilatory control: Determination of neurorespiratory maturation and predictors of co-morbidity risk
Integrated analysis of autonomic biomarkers in prematurity-related ventilatory control: Determination of neurorespiratory maturation and predictors of co-morbidity risk